Dimension Capital I, L.P. - 16 May 2024 SCHEDULE 13G Report for Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share (GLUE)

Filing Manager: Dimension Capital I, L.P.
Reporting Manager: Adam Goulburn
Security: Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: GLUE
Shares outstanding: 61,786,532 shares
Disclosed Ownership: 4,757,563 shares
Ownership: 7.7%
Form type: SCHEDULE 13G
Filing time: 03 Oct 2025, 12:19:09 UTC
Date of event: 16 May 2024
Next filing: 21 Jan 2026
SEC: View on sec.gov

Reporting Managers (7)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Adam Goulburn	7.7%	4,757,563	4,757,563	/s/ Adam Goulburn	Adam Goulburn
Zavain Dar	7.7%	4,757,563	4,757,563	/s/ Zavain Dar	Zavain Dar
Nan Li	7.7%	4,757,563	4,757,563	/s/ Nan Li	Nan Li
Dimension Management, L.P.	7.7%	4,757,563	4,757,563	/s/ Adam Goulburn	By: Dimension Management GP, LLC, its general partne; By: Adam Goulburn, Member
Dimension Capital I GP, LLC	7.7%	4,757,563	4,757,563	/s/ Adam Goulburn	Adam Goulburn, Member
Dimension Management GP, LLC	7.7%	4,757,563	4,757,563	/s/ Adam Goulburn	Adam Goulburn, Member
Dimension Capital I, L.P.	7.7%	4,757,563	4,757,563	/s/ Adam Goulburn	By: Dimension Capital I GP, LP, its general partner; By: Adam Goulburn, Member